Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.

<h4>Background</h4>Immune checkpoint inhibitors (ICIs) are highly effective in treating cancer; however, cardiotoxicity can occur, including myocarditis. Cardiac magnetic resonance (CMR) imaging is useful for evaluation of myocarditis, although it has not been well studied in ICI cardiot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Angela Y Higgins, Amit Arbune, Aaron Soufer, Elio Ragheb, Jennifer M Kwan, Jerome Lamy, Mariana Henry, Jason R Cuomo, Ahmad Charifa, Cesia Gallegos, Sarah Hull, Jessica Shank Coviello, Anna S Bader, Dana C Peters, Steffen Huber, Hamid R Mojibian, Albert J Sinusas, Harriet Kluger, Lauren A Baldassarre
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d60485952e1846e2a5ebdde4efb2f722
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d60485952e1846e2a5ebdde4efb2f722
record_format dspace
spelling oai:doaj.org-article:d60485952e1846e2a5ebdde4efb2f7222021-12-02T20:11:27ZLeft ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.1932-620310.1371/journal.pone.0246764https://doaj.org/article/d60485952e1846e2a5ebdde4efb2f7222021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0246764https://doaj.org/toc/1932-6203<h4>Background</h4>Immune checkpoint inhibitors (ICIs) are highly effective in treating cancer; however, cardiotoxicity can occur, including myocarditis. Cardiac magnetic resonance (CMR) imaging is useful for evaluation of myocarditis, although it has not been well studied in ICI cardiotoxicity.<h4>Methods</h4>We identified patients referred for CMR evaluation of ICI cardiotoxicity from September 2015 through September 2019. We assessed structural and functional parameters, feature tracking (FT) left ventricular and atrial strain, T2- weighted ratios and quantitative late gadolinium enhancement (LGE). We also applied the Updated Lake Louise Criteria for diagnosis of myocarditis.<h4>Results</h4>Of the 20 patients referred, the median left ventricular ejection fraction (LVEF) was 52.5% ± 19.1 and 50% had a normal LVEF (≥53%). FT strain analysis revealed an average abnormal global longitudinal strain (GLS) of -9.8%± 4.2%. In patients with a normal LVEF, the average GLS remained depressed at -12.3%± 2.4%. In all patients, GLS demonstrated a significant negative correlation with LVEF (rs = -0.64, p 0.002). Sixteen patients (80%) had presence of LGE (14 non-ischemic pattern and 2 ischemic). Percent LGE did not correlate with any CMR parameters and notably did not correlate with LVEF (rs = -0.29, p = 0.22) or GLS (rs = 0.10, p = 0.67), highlighting the value of tissue characterization beyond functional assessment. Nine patients (45%) met full Updated Lake Louise Criteria and 85% met at least one criterion, suggestive of myocarditis in the correct clinical context. Thirteen patients (65%) were treated for ICI-associated myocarditis and, of these, 54% (n = 7) had recovery of LVEF to normal. There was no correlation between LVEF (p = 0.47), GLS (0.89), or % LGE (0.15) and recovery of LVEF with treatment.<h4>Conclusion</h4>In patients with suspected ICI cardiotoxicity, CMR is an important diagnostic tool, even in the absence of overt left ventricular dysfunction, as abnormalities in left ventricular strain, T2 signal and LGE can identifying disease.Angela Y HigginsAmit ArbuneAaron SouferElio RaghebJennifer M KwanJerome LamyMariana HenryJason R CuomoAhmad CharifaCesia GallegosSarah HullJessica Shank CovielloAnna S BaderDana C PetersSteffen HuberHamid R MojibianAlbert J SinusasHarriet KlugerLauren A BaldassarrePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 2, p e0246764 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Angela Y Higgins
Amit Arbune
Aaron Soufer
Elio Ragheb
Jennifer M Kwan
Jerome Lamy
Mariana Henry
Jason R Cuomo
Ahmad Charifa
Cesia Gallegos
Sarah Hull
Jessica Shank Coviello
Anna S Bader
Dana C Peters
Steffen Huber
Hamid R Mojibian
Albert J Sinusas
Harriet Kluger
Lauren A Baldassarre
Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
description <h4>Background</h4>Immune checkpoint inhibitors (ICIs) are highly effective in treating cancer; however, cardiotoxicity can occur, including myocarditis. Cardiac magnetic resonance (CMR) imaging is useful for evaluation of myocarditis, although it has not been well studied in ICI cardiotoxicity.<h4>Methods</h4>We identified patients referred for CMR evaluation of ICI cardiotoxicity from September 2015 through September 2019. We assessed structural and functional parameters, feature tracking (FT) left ventricular and atrial strain, T2- weighted ratios and quantitative late gadolinium enhancement (LGE). We also applied the Updated Lake Louise Criteria for diagnosis of myocarditis.<h4>Results</h4>Of the 20 patients referred, the median left ventricular ejection fraction (LVEF) was 52.5% ± 19.1 and 50% had a normal LVEF (≥53%). FT strain analysis revealed an average abnormal global longitudinal strain (GLS) of -9.8%± 4.2%. In patients with a normal LVEF, the average GLS remained depressed at -12.3%± 2.4%. In all patients, GLS demonstrated a significant negative correlation with LVEF (rs = -0.64, p 0.002). Sixteen patients (80%) had presence of LGE (14 non-ischemic pattern and 2 ischemic). Percent LGE did not correlate with any CMR parameters and notably did not correlate with LVEF (rs = -0.29, p = 0.22) or GLS (rs = 0.10, p = 0.67), highlighting the value of tissue characterization beyond functional assessment. Nine patients (45%) met full Updated Lake Louise Criteria and 85% met at least one criterion, suggestive of myocarditis in the correct clinical context. Thirteen patients (65%) were treated for ICI-associated myocarditis and, of these, 54% (n = 7) had recovery of LVEF to normal. There was no correlation between LVEF (p = 0.47), GLS (0.89), or % LGE (0.15) and recovery of LVEF with treatment.<h4>Conclusion</h4>In patients with suspected ICI cardiotoxicity, CMR is an important diagnostic tool, even in the absence of overt left ventricular dysfunction, as abnormalities in left ventricular strain, T2 signal and LGE can identifying disease.
format article
author Angela Y Higgins
Amit Arbune
Aaron Soufer
Elio Ragheb
Jennifer M Kwan
Jerome Lamy
Mariana Henry
Jason R Cuomo
Ahmad Charifa
Cesia Gallegos
Sarah Hull
Jessica Shank Coviello
Anna S Bader
Dana C Peters
Steffen Huber
Hamid R Mojibian
Albert J Sinusas
Harriet Kluger
Lauren A Baldassarre
author_facet Angela Y Higgins
Amit Arbune
Aaron Soufer
Elio Ragheb
Jennifer M Kwan
Jerome Lamy
Mariana Henry
Jason R Cuomo
Ahmad Charifa
Cesia Gallegos
Sarah Hull
Jessica Shank Coviello
Anna S Bader
Dana C Peters
Steffen Huber
Hamid R Mojibian
Albert J Sinusas
Harriet Kluger
Lauren A Baldassarre
author_sort Angela Y Higgins
title Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
title_short Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
title_full Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
title_fullStr Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
title_full_unstemmed Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
title_sort left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/d60485952e1846e2a5ebdde4efb2f722
work_keys_str_mv AT angelayhiggins leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT amitarbune leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT aaronsoufer leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT elioragheb leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT jennifermkwan leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT jeromelamy leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT marianahenry leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT jasonrcuomo leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT ahmadcharifa leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT cesiagallegos leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT sarahhull leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT jessicashankcoviello leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT annasbader leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT danacpeters leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT steffenhuber leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT hamidrmojibian leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT albertjsinusas leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT harrietkluger leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
AT laurenabaldassarre leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity
_version_ 1718374913095499776